Really good point you make. Pretty sure there is no timeframe on deriving a benefit on the 2018 revenue. That would be difficult to argue against.mBeing profitable despite CV19 and a suspension would sink that argument pretty quickly
ISX Price at posting:
$1.07 Sentiment: Hold Disclosure: Held